News from NYU Langone Health
New York Post
A new report from the Leapfrog Group awarded top 'A' safety ratings to several NYC-area hospitals, including multiple NYU Langone Health facilities. The report recognized NYU Langone's Manhattan campus, NYU Langone Hospital—Brooklyn, and NYU Langone Hospital—Long Island. The health system noted it is among only 1% of hospitals nationwide to receive 11 consecutive 'A' grades. Alec C. Kimmelman, MD, PhD, dean of NYU Grossman School of Medicine and chief executive officer of NYU Langone Health, stated the ratings reflect the organization's commitment to safe, top-quality care. Other hospitals receiving 'A' grades included those from NewYork-Presbyterian and Northwell Health.
Also reporting was: , ,
11/12/2025
X-Ray Interpreter
Researchers at NYU Langone Health and Visage Imaging have developed an Al tool that analyzes routine CT scans to screen for signs of osteoporosis. Using data from over 538,000 scans across nearly 283,500 patients, the system measures bone mineral density of lumbar and thoracic vertebrae and accounts for age, gender, and race. he Al-enabled approach could double screening rates, uncover undiagnosed cases, and potentially save more than $2.5 billion annually in U.S. Medicare costs.
11/11/2025
The Sacramento Bee
A new study led by John A. Dodson, MD, MPH, director of NYU Langone's Geriatric Cardiology Program and an associate professor in the Department of Medicine's Leon H. Charney Division of Cardiology at NYU Langone Health, found that cash lottery rewards were ineffective in lowering blood pressure. While participants were twice as likely to take their medication when eligible for a daily cash reward, this behavior change did not translate to better blood pressure control compared to a control group. Researchers also found that participants stopped taking their medication as prescribed once the six-month rewards program concluded, suggesting that improving long-term medication adherence is more complex.
Also reporting was: , , , , , , , , , , , , , , , , , ,
11/12/2025
Georgetown News-Graphic
The U.S. Food and Drug Administration is removing its prominent 'black box' warnings from many hormone replacement therapy medications for menopausal women, citing outdated scientific data. The agency now recommends that women considering systemic HRT should begin treatment before age 60 or within 10 years of menopause onset. Samantha Dunham, MD, clinical associate professor, Department of Obstetrics and Gynecology at NYU Grossman School of Medicine and co-director, Center for Midlife Health and Menopause, commented that alternatives exist, such as cognitive therapy or non-hormonal medications, and emphasized that the decision to use HRT is between a patient and their doctor.
Also reporting was: , , , , , , , , , , , , , , , , ,
11/12/2025
Men's Health
An article on weight loss for people over 50 features advice from Holly F. Lofton, MD, clinical associate professor, Department of Surgery at NYU Grossman School of Medicine clinical associate professor, Department of Medicine at NYU Grossman School of Medicine. She recommends eating easily prepared vegetables, being mindful of sugar in smoothies, and planning meals while traveling to maintain structure. Dr. Lofton also advises that men over 50 review their medications with a healthcare provider, as some can contribute to weight gain. The article provides other general tips on diet, exercise, and sleep.
11/12/2025
Daily Express US
A study of over 100 million health records found a 27% to 33% lower risk of developing dementia over three years for patients who received the shingles vaccine. The research also found that multiple shingles episodes were associated with a 7-9% higher dementia risk. While most types of dementia cannot be cured, this research aids in finding ways to lower the risk. The article notes that dementia is also linked to genetic factors, hypertension, diabetes, obesity, and poor mental health, according to NYU Langone Health.
11/12/2025
TCTMD
A new meta-analysis published in the New England Journal of Medicine finds that beta-blockers offer no clinical benefit to post-myocardial infarction patients with preserved left ventricular ejection fraction. The study, which analyzed data from nearly 18,000 patients, showed no reduction in the primary composite endpoint of all-cause death, MI, or heart failure. Commenting on the findings, Sripal Bangalore, MD, MHA, FAHA, professor of medicine at NYU Grossman School of Medicine and director of Cardiac Catheterization Laboratory, stated that the data provide a definitive answer, reinforcing the need to reevaluate therapies based on decades-old trials.
11/12/2025
Optometry Times
In an interview, Angela Wen, OD, clinical instructor, Department of Ophthalmology at NYU Grossman School of Medicine, discusses contemporary glaucoma care. She identifies the Humphrey field analyzer as a cornerstone technology, stressing its value over optical coherence tomography in some cases. Wen, OD, asserts that eye drops remain a vital component of therapy, even with advancements in laser and surgical interventions, due to their practicality and patient adherence. She also recommends that general optometrists build collaborative relationships with ophthalmologists to improve their confidence and competence in managing complex glaucoma cases within a multidisciplinary setting.
11/12/2025
Scientific Inquirer
A new study co-authored by researchers from NYU Grossman School of Medicine’s Neuroscience Institute finds that estrogen boosts dopamine activity, which enhances learning capabilities. Published in Nature Neuroscience, the research on rats showed that increased estrogen levels made reward signals stronger, while suppressed estrogen diminished learning. Christine Constantinople, PhD, professor in NYU Langone's Center for Neural Science, and Carla Golden, an NYU postdoctoral fellow, notes that understanding how hormones influence neural circuits could reveal causes of neuropsychiatric disorders. The study also included Carla Golden, an NYU postdoctoral fellow.
11/12/2025
The East Hampton Star
Visual artist Margaret Garrett recently completed 'Whispers at Dusk,' a 40-foot-long glass mural commissioned by the NYU Langone Art Program and Collection for its new hospital in Garden City. The work spans eight nonreflective glass panels, combining digital UV printing with hand-done glass etching to reflect the textures of the original painting. Garrett, a former dancer who turned to visual art, discussed her inspirations and process at an event at The Church in Sag Harbor, where another of her works is on display.
11/13/2025
